Patient response and remission in respiratory disease: Special focus on severe asthma and chronic obstructive pulmonary disease
Over the past decades, monoclonal antibodies have been playing a pivotal role in the treatment of chronic inflammatory airway diseases. Currently, ample data are available on the efficacy and safety of biologics in asthma from randomized controlled trials and open-label trials; conversely, limited d...
Saved in:
| Main Authors: | Stefania Colantuono, Francesco Menzella, Pier-Valerio Mari, Francesco Macagno, Francesco Lombardi, Ilaria Baglivo, Cristiano Caruso |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-05-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/03000605251340894 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The importance of diet and metabolism: from nutrition to allergy and immunology
by: Stefania Colantuono, et al.
Published: (2022-10-01) -
Positioning tezepelumab for patients with severe asthma: from evidence to unmet needs
by: Carlo Lombardi, et al.
Published: (2024-11-01) -
Aspirin Hypersensitivity in Patients with Coronary Artery Disease: An Updated Review and Practical Recommendations
by: Luigi Cappannoli, et al.
Published: (2024-10-01) -
Glyphosate and Microbiota: controversies and truths
by: Stefania Colantuono, et al.
Published: (2023-11-01) -
The Impact of Corticosteroids on Mortality in Acute Exacerbations of Idiopathic Pulmonary Fibrosis: A Meta-Analysis
by: Pier-Valerio Mari, et al.
Published: (2025-03-01)